PL2207526T3 - Process for the manufacure of a pharmaceutical product comprising citric acid, magnesium oxide, potassium bicarbonate and sodium picosulfate, pharmaceutical composition comprising granules obtained by such process and intermediate products thereof - Google Patents
Process for the manufacure of a pharmaceutical product comprising citric acid, magnesium oxide, potassium bicarbonate and sodium picosulfate, pharmaceutical composition comprising granules obtained by such process and intermediate products thereofInfo
- Publication number
- PL2207526T3 PL2207526T3 PL08837670T PL08837670T PL2207526T3 PL 2207526 T3 PL2207526 T3 PL 2207526T3 PL 08837670 T PL08837670 T PL 08837670T PL 08837670 T PL08837670 T PL 08837670T PL 2207526 T3 PL2207526 T3 PL 2207526T3
- Authority
- PL
- Poland
- Prior art keywords
- manufacure
- citric acid
- magnesium oxide
- potassium bicarbonate
- intermediate products
- Prior art date
Links
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 title 3
- 239000008187 granular material Substances 0.000 title 1
- 239000013067 intermediate product Substances 0.000 title 1
- 239000000395 magnesium oxide Substances 0.000 title 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 title 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 229940127557 pharmaceutical product Drugs 0.000 title 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 title 1
- 235000015497 potassium bicarbonate Nutrition 0.000 title 1
- 239000011736 potassium bicarbonate Substances 0.000 title 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 title 1
- GOZDTZWAMGHLDY-UHFFFAOYSA-L sodium picosulfate Chemical compound [Na+].[Na+].C1=CC(OS(=O)(=O)[O-])=CC=C1C(C=1N=CC=CC=1)C1=CC=C(OS([O-])(=O)=O)C=C1 GOZDTZWAMGHLDY-UHFFFAOYSA-L 0.000 title 1
- 229960005077 sodium picosulfate Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/009—Sachets, pouches characterised by the material or function of the envelope
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/501—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07254049 | 2007-10-12 | ||
| US98054907P | 2007-10-17 | 2007-10-17 | |
| CNA2007101860236A CN101406457A (en) | 2007-10-12 | 2007-11-09 | Process for the manufacture of a pharmaceutical product |
| GB0805953A GB0805953D0 (en) | 2008-04-01 | 2008-04-01 | Process for the manufacture of a pharmaceutical product |
| EP08837670.2A EP2207526B1 (en) | 2007-10-12 | 2008-10-10 | Process for the manufacure of a pharmaceutical product comprising citric acid, magnesium oxide, potassium bicarbonate and sodium picosulfate, pharmaceutical composition comprising granules obtained by such process and intermediate products thereof |
| PCT/IB2008/003199 WO2009047633A2 (en) | 2007-10-12 | 2008-10-10 | Process for the manufacure of a pharmaceutical product comprising citric acid, magnesium oxide, potassium bicarbonate and sodium picosulfate, pharmaceutical composition comprising granules obtained by such process and intermediate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2207526T3 true PL2207526T3 (en) | 2018-06-29 |
Family
ID=42082803
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL08837670T PL2207526T3 (en) | 2007-10-12 | 2008-10-10 | Process for the manufacure of a pharmaceutical product comprising citric acid, magnesium oxide, potassium bicarbonate and sodium picosulfate, pharmaceutical composition comprising granules obtained by such process and intermediate products thereof |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US8481083B2 (en) |
| EP (1) | EP2207526B1 (en) |
| JP (1) | JP5654873B2 (en) |
| KR (2) | KR101381263B1 (en) |
| CN (1) | CN101820859B (en) |
| AU (1) | AU2008309287B2 (en) |
| BR (1) | BRPI0818541B8 (en) |
| CA (1) | CA2702152A1 (en) |
| DK (1) | DK2207526T3 (en) |
| ES (1) | ES2659716T3 (en) |
| HR (1) | HRP20180215T1 (en) |
| HU (1) | HUE038174T2 (en) |
| IL (1) | IL204500A (en) |
| JO (1) | JO3406B1 (en) |
| LT (1) | LT2207526T (en) |
| MX (1) | MX2010003588A (en) |
| NZ (1) | NZ583899A (en) |
| PL (1) | PL2207526T3 (en) |
| PT (1) | PT2207526T (en) |
| RU (1) | RU2473332C2 (en) |
| SI (1) | SI2207526T1 (en) |
| TW (1) | TWI418352B (en) |
| WO (1) | WO2009047633A2 (en) |
| ZA (1) | ZA201002131B (en) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8481083B2 (en) | 2007-10-12 | 2013-07-09 | Ferring International Center S.A. | Granular compositions of magnesium oxide and citric acid and uses thereof |
| KR101155099B1 (en) * | 2012-03-29 | 2012-06-11 | 남봉길 | Method for preparing intestinal lavage composition and composition for intestinal lavage produced thereby |
| US10166219B2 (en) * | 2012-07-27 | 2019-01-01 | Redhill Bipharma Ltd. | Formulations and methods of manufacturing formulations for use in colonic evacuation |
| JP2014224080A (en) * | 2013-05-17 | 2014-12-04 | 協和化学工業株式会社 | Treatment agent for colonic examination or surgery |
| KR101517520B1 (en) | 2013-08-05 | 2015-05-04 | 이희엽 | A process for preparing bowel cleansing composition containing pico sodium sulfate |
| IN2013MU02911A (en) * | 2013-09-10 | 2015-07-03 | Cadila Healthcare Ltd | |
| KR101420315B1 (en) | 2014-03-19 | 2014-07-17 | 남봉길 | Pharmaceutical liquid composition |
| SG10201909401UA (en) * | 2015-01-14 | 2019-11-28 | Pfizer | Oral delivery product |
| RU2018105869A (en) | 2015-08-17 | 2019-09-19 | Ферринг Б.В. | LIQUID COMPOSITIONS CONTAINING PICOSULFATE AND MAGNESIUM CITRATE |
| CN105456264B (en) * | 2015-12-03 | 2018-07-10 | 广州瑞尔医药科技有限公司 | Pharmaceutical composition of economic benefits and social benefits laxative and preparation method thereof |
| WO2018009761A1 (en) | 2016-07-08 | 2018-01-11 | Ferring B.V. | Stabilized liquid formulations containing picosulfate |
| US11471447B2 (en) | 2019-06-20 | 2022-10-18 | Hetero Labs Limited | Stable pharmaceutical product and vessel comprising sodium picosulfate, magnesium oxide and citric acid |
| WO2021056109A1 (en) * | 2019-09-24 | 2021-04-01 | Medisca Pharmaceutique Inc. | Gel base composition for compounding into a mucoadhesive delivery system |
| CN110638786A (en) * | 2019-10-09 | 2020-01-03 | 杭州百诚医药科技股份有限公司 | A kind of pharmaceutical composition and preparation method of sodium picosulfate, citric acid and magnesium oxide |
| CN113648327B (en) * | 2021-08-24 | 2023-03-28 | 山东京卫制药有限公司 | Pharmaceutical composition and preparation method thereof |
| CN115040512B (en) * | 2022-07-28 | 2023-06-20 | 苏州中化药品工业有限公司 | Pharmaceutical composition and preparation method thereof |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1300969A (en) | 1969-03-26 | 1972-12-29 | Organon Nv | Novel modified acid crystals and a process for their preparation |
| JPS5731864A (en) * | 1980-08-04 | 1982-02-20 | Teijin Ltd | Oral activated carbon microcapsule |
| US5290962A (en) * | 1989-09-06 | 1994-03-01 | Exxon Chemical Patents Inc. | Method for preparation of anti-calking coating with pigment therein |
| GB9011034D0 (en) | 1990-05-16 | 1990-07-04 | Programme 3 Patent Holdings | Electrochemical cell |
| US5045459A (en) * | 1990-10-05 | 1991-09-03 | Haarmann & Reimer Corp. | Method for the production of granular citric acid |
| US5102682A (en) | 1991-01-31 | 1992-04-07 | Kraft General Foods, Inc. | Sucrose and fructose-containing food mix and process |
| US5219598A (en) | 1991-11-15 | 1993-06-15 | Kraft General Foods, Inc. | Reducing sugar-containing mix and process therefore |
| WO1995011024A1 (en) * | 1993-10-19 | 1995-04-27 | The Procter & Gamble Company | Picosulphate dosage form |
| US5498425A (en) * | 1995-03-17 | 1996-03-12 | Block Drug Company, Inc. | Phosphosoda buffered saline laxative |
| US5674529A (en) * | 1995-06-06 | 1997-10-07 | Church & Dwight Co., Inc. | Alkalinizing potassium salt controlled release preparations |
| CA2186938A1 (en) | 1995-10-18 | 1997-04-19 | Dalip K. Nayyar | Dry mix for producing a slush beverage |
| AUPN634595A0 (en) * | 1995-11-03 | 1995-11-30 | Borody, Thomas Julius | Improved method for colonic evacuation |
| DE19962251A1 (en) * | 1999-12-22 | 2001-09-06 | Hermes Fabrik Pharm Praeparate | Lozenge with thermally neutral dissolution properties containing active substance with exothermic dissolution behavior and compensatory adjuvant with endothermic dissolution behavior |
| US6514537B1 (en) * | 2000-06-02 | 2003-02-04 | Cumberland Swan Holdings, Inc. | Magnesium citrate solution |
| AUPS088702A0 (en) * | 2002-03-04 | 2002-03-28 | Borody, Thomas Julius | Electrolyte purgative |
| US20040115265A1 (en) | 2002-12-11 | 2004-06-17 | Loutfy Benkerrour | Multilayered tablet containing pravastatin and aspirin and method |
| US7758906B2 (en) | 2006-01-20 | 2010-07-20 | Kraft Foods Global Brands Llc | Thickening system for products prepared with milk |
| US8481083B2 (en) | 2007-10-12 | 2013-07-09 | Ferring International Center S.A. | Granular compositions of magnesium oxide and citric acid and uses thereof |
-
2008
- 2008-10-10 US US12/677,857 patent/US8481083B2/en active Active
- 2008-10-10 ES ES08837670.2T patent/ES2659716T3/en active Active
- 2008-10-10 EP EP08837670.2A patent/EP2207526B1/en active Active
- 2008-10-10 KR KR1020137023315A patent/KR101381263B1/en active Active
- 2008-10-10 JP JP2010528503A patent/JP5654873B2/en active Active
- 2008-10-10 AU AU2008309287A patent/AU2008309287B2/en active Active
- 2008-10-10 PL PL08837670T patent/PL2207526T3/en unknown
- 2008-10-10 HU HUE08837670A patent/HUE038174T2/en unknown
- 2008-10-10 NZ NZ583899A patent/NZ583899A/en unknown
- 2008-10-10 BR BRPI0818541A patent/BRPI0818541B8/en active IP Right Grant
- 2008-10-10 LT LTEP08837670.2T patent/LT2207526T/en unknown
- 2008-10-10 DK DK08837670.2T patent/DK2207526T3/en active
- 2008-10-10 CN CN2008801112524A patent/CN101820859B/en not_active Ceased
- 2008-10-10 SI SI200831915T patent/SI2207526T1/en unknown
- 2008-10-10 RU RU2010112483/15A patent/RU2473332C2/en active
- 2008-10-10 HR HRP20180215TT patent/HRP20180215T1/en unknown
- 2008-10-10 PT PT88376702T patent/PT2207526T/en unknown
- 2008-10-10 CA CA2702152A patent/CA2702152A1/en not_active Abandoned
- 2008-10-10 WO PCT/IB2008/003199 patent/WO2009047633A2/en not_active Ceased
- 2008-10-10 KR KR1020107007932A patent/KR101330096B1/en active Active
- 2008-10-10 MX MX2010003588A patent/MX2010003588A/en active IP Right Grant
- 2008-10-12 JO JOP/2008/0454A patent/JO3406B1/en active
- 2008-10-13 TW TW097139185A patent/TWI418352B/en active
-
2010
- 2010-03-15 IL IL204500A patent/IL204500A/en active IP Right Grant
- 2010-03-25 ZA ZA2010/02131A patent/ZA201002131B/en unknown
-
2011
- 2011-09-27 US US13/246,739 patent/US8450338B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2207526T3 (en) | Process for the manufacure of a pharmaceutical product comprising citric acid, magnesium oxide, potassium bicarbonate and sodium picosulfate, pharmaceutical composition comprising granules obtained by such process and intermediate products thereof | |
| IL215065A (en) | Proline derivatives, process for their preparation, pharmaceutical compositions comprising said derivatives and use thereof for the preparation of medicaments | |
| IL195142A (en) | Substituted arylimidazolone and triazolone, process for their preparation and pharmaceutical compositions comprising the same for the treatment or prophylaxis of diseases | |
| WO2011127290A3 (en) | Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid | |
| IL184771A (en) | Compositions comprising n-halogenated amino acids and n,n- dihalogenated amino acids, their use for the manufacture of antibacterial medicaments, pharmaceutical compositions comprising them and a process for their preparation | |
| IL217036A (en) | Acetylsalicylic acid addition salt, uses thereof in the preparation of medicaments, pharmaceutical compositions comprising the same and a combination medicinal product comprising such acid addition salt | |
| IL190137A (en) | Mixtures of crystalline laquinimod sodium particles, pharmaceutical compositions comprising them and process for the manufacture thereof | |
| IL223795A (en) | Tetrahydro-pyrido-pyrimidine derivatives, process for their preparation, pharmaceutical compositions comprising them and use thereof in the manufacture of medicaments | |
| IL204052A (en) | 1,1,1- trifluoro-2- hydroxy-3- phenylpropane derivatives, process for their manufacture, pharmaceutical compositions comprising the same and uses thereof for the preparation of medicaments | |
| WO2010139979A3 (en) | Processes for preparing crystalline forms of dasatinib | |
| IL203936A (en) | Derivatives of 4-pyrimidinesulfamide, process for their preparation, pharmaceutical compositions comprising them and their use in the manufacture of medicaments | |
| WO2010092090A3 (en) | Novel salts of sitagliptin | |
| PL2066300T3 (en) | Self-preserved aqueous pharmaceutical compositions | |
| IL201189A (en) | Fluorinated derivatives of deferiprone for use as iron chelators in the treatment of neurodegenerative diseases, process for their preparation and pharmaceutical compositions comprising them | |
| IL223872A (en) | Pyrazoloquinolines and intermediate compounds, process for their preparation, use thereof and medicaments and pharmaceutical compositions comprising them | |
| IL213983A (en) | Heteroaryl substituted pyridazinone derivatives, process for their preparation, pharmaceutical compositions comprising them and use thereof in the manufacture of medicaments | |
| HK1201477A1 (en) | Pharmaceutical composition of omeprazole | |
| IL213671A (en) | Pharmaceutical compositions comprising aleglitazar, process for their manufacture and use thereof in the preparation of medicaments | |
| IL218044A (en) | (trihalophenyl-methyl)-(1-halophenyl-2-imidazolyl-ethyl)-ethers, process for their preparation and pharmaceutical compositions comprising them | |
| ZA200800729B (en) | A crystalline form of the zoledronic acid, a process to obtain it and the pharmaceutical composition comprising it | |
| WO2011027258A3 (en) | Scented capsules | |
| IL213105A (en) | Compounds, a process for the preparation thereof, pharmaceutical compositions comprising them and uses thereof in the manufacture of medicaments | |
| HUP0600293A2 (en) | Zinc salt of rosuvastatine, process for its preparation and pharmaceutical compositions containing it | |
| HUP0600808A3 (en) | New benzamide derivatives as bradykinin antagonists, process for their preparation and pharmaceutical compositions containing them | |
| ZA200806399B (en) | Novel pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamines, process for the preparation thereof and pharmaceutical compositions containing them |